ARway.ai Issues Stock Options

Rhea-AI Summary

ARway.ai, an AI-powered Augmented Reality Experience platform (CSE:ARWY, OTCQB:ARWYF, FSE:E65), has announced the issuance of stock options to key personnel. The company has granted 50,000 two-year stock options at $0.055 per share to new board member Peter Bloch, 500,000 two-year stock options at $0.055 per share to CFO Anum Wagas, and 50,000 two-year stock options at $0.055 per share to board member Anthony Pizzonia.

Peter Bloch brings significant experience as a CPA, CA, with a history of building technology companies, particularly in life sciences. His previous roles include CEO positions at BresoTEC and Bionik Laboratories, and CFO positions at several major companies including Sanofi Canada, Intellivax, and Just Energy.

Positive

• Addition of experienced board member Peter Bloch with extensive public company management experience
• Stock option grants align management interests with shareholders

Negative

• Potential dilution from issuance of 600,000 stock options

TORONTO, ON / ACCESSWIRE / January 10, 2025 / ARway.ai ("ARway" or the "Company") (CSE:ARWY)(OTCQB:ARWYF)(FSE:E65) is an AI powered Augmented Reality Experience platform with a disruptive no-code, no beacon spatial computing solution enabled by visual marker tracking with centimeter precision announces the issuance of stock options.

ARway.ai issued Peter Bloch, a successful entrepreneur and new BOD member 50,000 2-year stock options exercisable at .055/share. The company also issued 500,000 2-year .055/share options to Anum Wagas CFO. BOD member Anthony Pizzonia was also issued 50,000 2 year stock options at .055/share.

Bio:

Peter Bloch was the Chief Executive Officer of BresoTEC Inc. Mr. Bloch was also the CEO & Chairman of Bionik Laboratories from 2012 to 2018. Mr. Bloch is a CPA, CA, with a track record of building both public and private technology companies, mainly in the life sciences industry. In these roles, Mr. Bloch has secured significant funding for both private and public companies, gained experience with initial public offerings and led a number of acquisitions and partnership transactions. His past 25 years of executive management experience includes serving as Chief Financial Officer and joint interim CEO of Sanofi Canada Inc., the Canadian affiliate of Sanofi -Aventis, a global healthcare leader; Chief Financial Officer of Intellivax Inc., a biotechnology company which was sold to GlaxoSmithKline for $1.75 billion; founder of Tribute Pharmaceuticals, a specialty pharmaceutical company; the Chief Financial Officer of Gennum Corporation, a public semiconductor company focused on the TV and medical device market and Chief Financial Officer of Just Energy, a large public electricity and gas company . These companies have ranged in size from start-ups to companies with revenues of over $2 billion. Mr. Bloch also has substantial experience serving on the Board of Directors of both public and private companies. Mr. Bloch also serves as an advisor to Mars Discovery District, a large Canadian incubator for technology companies.

Sign up for Investor News - HERE

To learn more about ARway, please follow on Social Media: Twitter, YouTube, Instagram, LinkedIn, and Facebook, and visit our website: www.arway.ai

About ARway.ai
ARway.ai (CSE: ARWY) (OTCQB: ARWYF) (FSE: E65) is a spatial computing platform powered by artificial intelligence (AI) providing an array of augmented reality (AR) experiences for indoor spaces. ARway's breakthrough no-code no-beacon IPN allows for the easy creation of navigation, tours, information sharing, notifications, advertising and gamification. ARway works seamlessly as a cross platform solution on iOS/ Android. ARway's technology is optimized for both mobile devices and AR glasses: Apple's Vision Pro, Magic Leap and Microsoft's HoloLens. ARway has unlimited use cases for augmenting physical spaces, making it a valuable tool for creators, brands and companies in various industries. The complete ARway platform includes: the Web Creator Studio, the ARwayKit Software Development Kit (SDK) and a mobile app for iOs and Android.

Nextech 3D.ai
On October 26, 2022, ARway.ai. was spun-out from its parent Company, Nextech3D.ai (OTCQX: NEXCF) (CSE: NTAR) (FSE: 1SS). Nextech retained a control ownership in ARway.ai. with 13 million shares, or a 50% stake. Nextech3D.ai is a Generative AI powered 3D modeling Company and leading provider of augmented reality ("AR") experience technologies and 3D model services. Nextech's AI-powered 3D modeling platform, "ARitize3D" has contracts with; AMZN, KSS, CB2, Genuine Parts & many others. To learn more about Nextech3D.ai, visit www.nextechar.com

For further information, please contact:

Investor Relations Contact
investor.relations@arway.ai

ARway.ai
Evan Gappelberg
CEO and Director
866-ARITIZE (274-8493)

Forward-looking Statements 

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release. 

Certain information contained herein may constitute "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, "will be" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements regarding the completion of the transaction are subject to known and unknown risks, uncertainties and other factors. There can be no assurance that such statements will prove to be accurate, as future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. ARway.ai will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

SOURCE: ARway Corporation

View the original press release on accesswire.com

FAQ

How many stock options did ARway.ai (ARWYF) issue in January 2024?

ARway.ai issued a total of 600,000 stock options, with 500,000 going to CFO Anum Wagas and 50,000 each to board members Peter Bloch and Anthony Pizzonia.

What is the exercise price of ARWYF's newly issued stock options?

The stock options were issued at an exercise price of $0.055 per share.

What is the expiration term for ARway.ai's (ARWYF) new stock options?

The stock options have a two-year term before expiration.

What is Peter Bloch's background joining ARway.ai's (ARWYF) board?

Peter Bloch is a CPA, CA with extensive executive experience, including CEO roles at BresoTEC and Bionik Laboratories, and CFO positions at companies like Sanofi Canada and Just Energy.